Jazz Pharmaceuticals filed required documentation with the SEC regarding market transparency on June 11, 2026.

The entities involved

• Jazz Pharmaceuticals →

  Irish tax-registered pharmaceutical corporation

  • Jazz Pharmaceuticals plans U.S. launch of Ziihera.Wed 22:28
  • Alan M. Sebulsky was appointed to the Board of Directors of MeiraGTx Holdings PLC, where he has previously served.Wed 13:55
• SEC →

  Slovak company

  • DHS, DOJ, and SEC formed a joint initiative to establish a Trade Fraud Task Force, setting standards for compliance.Mon 17:57
  • The Fidelis Partnership is incorporating in Bermuda and filing for an initial public offering on the NYSE, with principal offices in London and a main office in Dublin.Mon 17:12

Related events

• Jazz Pharmaceuticals guaranteed notes issued by its subsidiary, Jazz Investments I Limited, on August 26, 2026.Aug 26
• Jazz Pharmaceuticals received FDA approval for a drug following positive clinical trial results.Aug 31
• Entergy made required filings with the SEC regarding stock purchases on June 18, 2026.Jun 18
• Applied Materials filed reports with the SEC on June 15, 2026.Jun 15
• Corcept Therapeutics made required filings with the SEC regarding institutional holdings on June 16, 2026.Jun 16